What PRA Health Sciences, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 0 |
| Sells | 0 | 0 |
| Total trades | 0 | 0 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 0 |
| Disposed | 0 | 0 |
| Net activity | +0 | +0 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Young Matthew P. | Director | Jul 01 | Disposition to Issuer · D | −7,127 | — | — | 0 |
| Momtazee James C | Director | Jul 01 | Disposition to Issuer · D | −3,521 | — | — | 0 |
| Grais Linda S | Director | Jul 01 | Disposition to Issuer · D | −9,683 | — | — | 0 |
| Barber Jeffrey T | Director | Jul 01 | Disposition to Issuer · D | −14,729 | — | — | 0 |
| Stettin Glen D. | Director | Jul 01 | Disposition to Issuer · D | −1,049 | — | — | 0 |
| Dickinson Alexander George | Director | Jul 01 | Disposition to Issuer · D | −5,407 | — | — | 0 |
| Shannon Colin | President & CEO | Jul 01 | Disposition to Issuer · D | −46,500 | — | — | 0 |
| Bonello Michael J. | EVP & CFO | Jul 01 | Disposition to Issuer · D | −4,480 | — | — | 0 |
| Gaenzle Christopher L | EVP, CAO & General Counsel | Jul 01 | Disposition to Issuer · D | −34,500 | — | — | 0 |
| Shannon Colin | President & CEO | Jun 17 | Disclosed 10b5-1 sale · S | −59,774 | $169.63 | −$10.1M | 54,626 |
| Shannon Colin | President & CEO | Jun 17 | Disclosed 10b5-1 sale · S | −220,195 | $169.00 | −$37.2M | 114,400 |
| Shannon Colin | President & CEO | Jun 17 | Disclosed 10b5-1 sale · S | −161,352 | $168.13 | −$27.1M | 334,595 |
| Shannon Colin | President & CEO | Jun 17 | Disclosed 10b5-1 sale · S | −920 | $166.89 | −$154K | 495,947 |
| Shannon Colin | President & CEO | Jun 17 | Exercise / conversion · M | +31,780 | $103.30 | +$3.28M | 496,867 |
| Shannon Colin | President & CEO | Jun 17 | Exercise / conversion · M | +45,000 | $102.44 | +$4.61M | 465,087 |
| Shannon Colin | President & CEO | Jun 17 | Exercise / conversion · M | +31,000 | $95.94 | +$2.97M | 420,087 |
| Shannon Colin | President & CEO | Jun 17 | Exercise / conversion · M | +91,000 | $75.81 | +$6.9M | 389,087 |
| Shannon Colin | President & CEO | Jun 17 | Exercise / conversion · M | +166,036 | $11.73 | +$1.95M | 298,087 |
| Shannon Colin | President & CEO | Jun 17 | Exercise / conversion · M | +77,425 | $11.73 | +$908K | 132,051 |
| Gaenzle Christopher L | EVP, CAO & General Counsel | Jun 17 | Disclosed 10b5-1 sale · S | −692 | $169.75 | −$117K | 34,500 |
Loading...
